(Q42844339)

English

The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge

scientific article published on October 2010

Statements

The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge (English)
Franck E Nicolini
Jean-Claude Chomel
Sophie Ducastelle
Emmanuelle Nicolas-Virelizier
Mauricette Michallet
Jean-Pierre Magaud
François Guilhot
Sandrine Hayette

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit